Alintosch Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 4.50 M
- Company Age 38 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
- Revenue Growth 41696.00%
- Profit Growth -14.21%
- Ebitda 24.48%
- Net Worth -12.91%
- Total Assets 60.58%
About Alintosch Pharmaceuticals
Alintosch Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 September 1986 and has a history of 38 years and five months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Alintosch Pharmaceuticals Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹5.00 Cr.
Pranavkumar Sharma, Bharatbhushan Shrikhande, and Siddhesh Sharma serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1986PTC040884
- Company No.
040884
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Alintosch Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddhesh Sharma  | Director | 15-Sep-2003 | Current |
| Pranavkumar Sharma | Director | 15-Sep-2003 | Current |
| Bharatbhushan Shrikhande | Director | 14-Sep-1991 | Current |
Financial Performance of Alintosch Pharmaceuticals.
Alintosch Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41696% increase. The company also saw a substantial fall in profitability, with a 14.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alintosch Pharmaceuticals?
In 2023, Alintosch Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Naturedge Beverages Private LimitedSiddhesh Sharma is a mutual person
Siddhayu Healthcare Private LimitedPranavkumar Sharma and Bharatbhushan Shrikhande are mutual person
- Siddhayu Ayurvedic Research Foundation Pvt Ltd
Bharatbhushan Shrikhande and Siddhesh Sharma are mutual person
Baidyanath Power Private LimitedPranavkumar Sharma is a mutual person
Baidyanath Horti.Agro And Plantations Private LimitedPranavkumar Sharma and Siddhesh Sharma are mutual person
Baidyanath Ayurved Bhawan Advertising And Marketing Pvt LtdPranavkumar Sharma and Siddhesh Sharma are mutual person
Charges (Loans)
₹5.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Sep 2022 | Others | ₹5.00 Cr | Open |
How Many Employees Work at Alintosch Pharmaceuticals?
Unlock and access historical data on people associated with Alintosch Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alintosch Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alintosch Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
